Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 50Lung Neoplasms 25Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Neoplasm Metastasis 6Colorectal Neoplasms 5Pancreatic Neoplasms 4Mesothelioma, Malignant 3Melanoma 3Colonic Neoplasms 3Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Non-squamous Non-small Cell Lung Cancer 2Neoplasms by Site 2Mesothelioma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Adenocarcinoma of Lung 2Vaccinia 1Uterine Cervical Neoplasms 1Thoracic Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1

Interventions

Cyclophosphamide 4Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2liposomal doxorubicin 2ivosidenib 2cabozantinib 2X-Rays 2Topotecan 2Specimen Handling 2Radiation 2Phantoms, Imaging 2Nuclear Medicine Department, Hospital 2Irinotecan 2Eflornithine 2Congresses as Topic 2trifluridine tipiracil drug combination 1tazemetostat 1talazoparib 1palbociclib 1olaparib 1larotrectinib 1irinotecan sucrosofate 1ganitumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Pemetrexed × 30 days × Clear all
NCT03715933 2026-05-22

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Inhibrx Biosciences, Inc

Phase 1 Recruiting
411 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡